Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010-2018.
Ina-Maria Rückert-EhebergMichael NoldeNayeon AhnMartin TauscherRoman GerlachFlorian GüntnerAlexander GünterChrista MeisingerJakob LinseisenUte AmannSebastian-Edgar BaumeisterPublished in: European journal of clinical pharmacology (2021)
The utilization of prescribed PPIs has decreased since 2016. However, a large proportion of new PPI-users had no documentation of a potential indication, and the sums of DDDs prescribed often seemed not to comply with guidelines.